Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

BioTechHealthX Aug. 23 at 3:58 PM

$CLPT $MASS $OSUR $PDEX $SERA Discover 5 high-potential small-cap medical stocks ranked by revenue growth, commercial traction, financial strength, catalysts, valuation, and overall investment risk. https://biotechhealthx.com/biotech-news/top-10-small-cap-medical-stocks-to-buy-before-august-2026-ends/

0 · Reply

MAGA1717 Aug. 21 at 6:44 PM

$CLPT 🤡🤡🤡👇

1 · Reply

RichSaunder Aug. 21 at 5:00 PM

$CLPT

1 · Reply

RichSaunder Aug. 21 at 4:59 PM

$CLPT

0 · Reply

hmellon1 Aug. 21 at 3:57 PM

$CLPT

0 · Reply

Thelonius_Stonk Aug. 20 at 11:31 PM

$CLPT epic potential

1 · Reply

Twister8 Aug. 20 at 7:09 PM

$CLPT shots on goal

0 · Reply

Twister8 Aug. 20 at 7:08 PM

$CLPT a CLPT partner?

1 · Reply

Twister8 Aug. 19 at 10:05 PM

$CLPT https://x.com/FoxNews/status/2090139876628819969?s=20

2 · Reply

WonderfulMongoose Aug. 19 at 4:07 PM

$CLPT 😂😂😂

0 · Reply

ClearPoint Neuro price target lowered to $25 from $30 at Lake Street

2026-08-04T11:02:05.000Z - 19 days ago

ClearPoint Neuro price target lowered to $22 from $25 at Stifel

2026-08-03T20:46:19.000Z - 19 days ago

ClearPoint Neuro cuts FY26 revenue view to $48M-$52M from $52M-$56M

2026-08-03T20:40:24.000Z - 19 days ago

ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)

Aug 3, 2026, 4:30 PM EDT - 19 days ago

ClearPoint Neuro Earnings Call Transcript: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 19 days ago

ClearPoint Neuro Earnings release: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 19 days ago

ClearPoint Neuro Slides: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 19 days ago

ClearPoint Neuro Quarterly report: Q2 2026

Aug 3, 2026, 4:05 PM EDT - 20 days ago

ClearPoint Neuro Reports Second Quarter 2026 Results

Jul 31, 2026, 4:05 PM EDT - 23 days ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

Jul 21, 2026, 4:05 PM EDT - 4 weeks ago

ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

2026-06-18T12:57:23.000Z - 2 months ago

ClearPoint Neuro price target raised to $30 from $20 at B. Riley

QURE

2026-06-17T12:43:10.000Z - 2 months ago

ClearPoint Neuro up 32% after uniQure announces plan for AMT-130 BLA submission

QURE

2026-05-27T20:51:32.000Z - 3 months ago

ClearPoint Neuro enters development partnership with Sungkyunkwan University

May 27, 2026, 4:30 PM EDT - 3 months ago

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-05-13T21:56:29.000Z - 3 months ago

ClearPoint Neuro receives CE Marking for Velocity Alpha MR

2026-05-13T21:26:39.000Z - 3 months ago

ClearPoint Neuro reports Q1 EPS (32c) vs. (22c) last year

2026-05-13T21:24:39.000Z - 3 months ago

ClearPoint Neuro sees FY26 revenue $52M-$56M, consensus $53.03M

May 13, 2026, 4:30 PM EDT - 3 months ago

ClearPoint Neuro Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

ClearPoint Neuro Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

ClearPoint Neuro Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 3 months ago

ClearPoint Neuro Reports First Quarter 2026 Results

May 13, 2026, 4:00 PM EDT - 3 months ago

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

May 13, 2026, 7:00 AM EDT - 3 months ago

ClearPoint Neuro Slides: Investor presentation

2026-05-08T13:16:56.000Z - 3 months ago

ClearPoint Neuro resumed with a Buy at Stifel

Apr 29, 2026, 4:05 PM EDT - 4 months ago

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

Apr 23, 2026, 8:00 AM EDT - 4 months ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-04-22T21:06:43.000Z - 4 months ago

ClearPoint Neuro announces first clinical use of Velocity Alpha MR drill

Apr 22, 2026, 4:05 PM EDT - 4 months ago

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-04-20T20:16:48.000Z - 4 months ago

ClearPoint Neuro announces Canadian approval for Neuro Navigation System

Apr 20, 2026, 4:05 PM EDT - 4 months ago

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Apr 10, 2026, 8:00 AM EDT - 4 months ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-03-18T12:50:37.000Z - 5 months ago

ClearPoint Neuro price target raised to $20 from $18 at B. Riley

Mar 17, 2026, 4:30 PM EDT - 5 months ago

ClearPoint Neuro Earnings Call Transcript: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 5 months ago

ClearPoint Neuro Annual report: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 5 months ago

ClearPoint Neuro Earnings release: Q4 2025

Mar 17, 2026, 4:05 PM EDT - 5 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Mar 17, 2026, 7:00 AM EDT - 5 months ago

ClearPoint Neuro Slides: Corporate presentation

Mar 6, 2026, 8:00 AM EST - 6 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

2026-03-05T14:22:39.000Z - 6 months ago

ClearPoint Neuro price target lowered to $18 from $28 at B. Riley

QURE

Jan 22, 2026, 4:30 PM EST - 7 months ago

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

Jan 14, 2026, 7:00 AM EST - 7 months ago

ClearPoint Neuro Registration statement: Registration Filing

Jan 12, 2026, 8:30 AM EST - 7 months ago

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Nov 20, 2025, 5:00 PM EST - 9 months ago

ClearPoint Neuro Completes Acquisition of IRRAS

Nov 6, 2025, 4:55 PM EST - 10 months ago

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:50 PM EST - 10 months ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 6, 2025, 4:30 PM EST - 10 months ago

ClearPoint Neuro Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

ClearPoint Neuro Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

ClearPoint Neuro Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

ClearPoint Neuro Slides: Investor Presentation

Nov 5, 2025, 5:02 PM EST - 10 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Oct 7, 2025, 4:15 PM EDT - 11 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 11 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 1, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 12, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings release: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 12, 2025, 7:00 AM EDT - 1 year ago

ClearPoint Neuro Slides: Investor Presentation

Aug 4, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

May 13, 2025, 4:40 PM EDT - 1 year ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings release: Q1 2025

May 12, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Apr 9, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Proxy statement: Proxy Filing

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q4 2024

Feb 26, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 1 year ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Slides: Q2 2024

Jul 17, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 20, 2024, 8:45 AM EDT - 2 years ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 2 years ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 2 years ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Quarterly report: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q1 2024

Apr 16, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Apr 5, 2024, 8:00 AM EDT - 2 years ago

ClearPoint Neuro Proxy statement: Proxy Filing

Mar 19, 2024, 8:07 AM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Annual report: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q4 2023

Mar 12, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Feb 29, 2024, 8:00 AM EST - 2 years ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

Feb 28, 2024, 4:45 PM EST - 2 years ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

BioTechHealthX Aug. 23 at 3:58 PM

0 · Reply

MAGA1717 Aug. 21 at 6:44 PM

$CLPT 🤡🤡🤡👇

1 · Reply

RichSaunder Aug. 21 at 5:00 PM

$CLPT

1 · Reply

RichSaunder Aug. 21 at 4:59 PM

$CLPT

0 · Reply

hmellon1 Aug. 21 at 3:57 PM

$CLPT

0 · Reply

Thelonius_Stonk Aug. 20 at 11:31 PM

$CLPT epic potential

1 · Reply

Twister8 Aug. 20 at 7:09 PM

$CLPT shots on goal

0 · Reply

Twister8 Aug. 20 at 7:08 PM

$CLPT a CLPT partner?

1 · Reply

Twister8 Aug. 19 at 10:05 PM

$CLPT https://x.com/FoxNews/status/2090139876628819969?s=20

2 · Reply

WonderfulMongoose Aug. 19 at 4:07 PM

$CLPT 😂😂😂

0 · Reply

MAGA1717 Aug. 19 at 3:04 PM

$CLPT hows your short 🤡🤡🤡🤡🤡👇

0 · Reply

JFDI Aug. 19 at 1:45 PM

$CLPT could look like one of those monsters out of this big base.

0 · Reply

Thinkingman91 Aug. 18 at 10:40 PM

$CLPT $QURE 4 year data readout and submission to the fda both due in 30 days. 3 year data took CLPT to $26 and QURE to $72. CLPT has at least 10 more data readouts in the next 18

0 · Reply

Thinkingman91 Aug. 18 at 2:28 PM

$CLPT ok you are here now pop

0 · Reply

Twister8 Aug. 17 at 10:32 PM

$CLPT dilution impending...

2 · Reply

JFDI Aug. 17 at 7:29 PM

$CLPT is back the game.

1 · Reply

ChineseTakeeout Aug. 17 at 2:32 PM

$CLPT $QURE Easy double in 1-2 months

0 · Reply

healthcareguru Aug. 14 at 6:36 PM

$HTFL now at 12x 2027e EV/sales and 15x EV/GP…PURE INSANITY!!! Sooooo overvalued. This will be back to $30 in quick order. In top 3 most ridiculously stretched valuations on my entire watch list. $KMTS $CLPT also STUPID! 😂 TONS of VCs still left to dump this TOO…>30% of shares still waiting to be liquidated. 👎 $XLV $IWM

2 · Reply

ChineseTakeeout Aug. 14 at 2:37 PM

$CLPT Rose to 30 on $QURE annoucement last year whereas $QURE went to ~70. Isn't $CLPT the better buy assuming $QURE gets approval based on this alone? Lower float means more gains on the same catalyst

1 · Reply

WonderfulMongoose Aug. 13 at 8:38 PM

$CLPT "We are laughing" -Ron Burgundy

0 · Reply

Thinkingman91 Aug. 13 at 7:11 PM

$CLPT when

1 · Reply

Thinkingman91 Aug. 13 at 7:10 PM

$CLPT when is that offering I was told wouldn’t occur here

0 · Reply

Market Cap	469.46M
Revenue (ttm)	36.97M
Net Income (ttm)	-25.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-69.08%
Debt to Equity Ratio	4.66

Volume	560,700
Avg Vol	764,248
Day's Range	N/A - N/A
Shares Out	30.50M
Stochastic %K	60%
Beta	1.24
Analysts	Strong Sell
Price Target	$25.67